The Cost Effectiveness of Antiretroviral Regimens for the Treatment of HIV/AIDS View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2000-10

AUTHORS

Aslam H. Anis, Daphne Guh, Robert S. Hogg, Xiao-Hua Wang, Benita Yip, Kevin J. P. Craib, Michael V. O’Shaughnessy, Martin T. Schechter, Julio S. G. Montaner

ABSTRACT

OBJECTIVE: To estimate survival, the number of life-years gained and cost effectiveness of antiretroviral therapy (ART) regimens, denoted as ERA-I [zidovudine + (didanosine or zalcitabine)]; ERA-II [stavudine + (didanosine or zalcitabine) or lamivudine + (zidovudine or didanosine or zalcitabine or stavudine)]; and ERA-III [2 nucleoside reverse transcriptase inhibitors + (1 protease inhibitor or 1 non-nucleoside reverse transcriptase inhibitor)]. DESIGN: Modelling of drug cost, cost of opportunistic diseases and survival of HIV positive men and women in the province of British Columbia who were first prescribed any ART between October 1992 and June 1996. A 'reference cohort' was modelled upon individuals in a longitudinal cohort of homosexual men followed since 1982. PERSPECTIVE AND SETTING: Third-party payer perspective in British Columbia, Canada. PATIENTS: All HIV-positive men and women aged > or =18 years with CD4+ counts < or =350 cells/microL who were enrolled in the province-wide drug treatment programme. MAIN OUTCOME MEASURES: Annual costs, survival and cost-effectiveness ratios of successive ART regimens. RESULTS: Total costs [1997 Canadian dollars ($Can)] at 12 months under ERA-I, -II and -III were $Can4897, $Can6620 and $Can 11 914, respectively. Survival at 12 months under ERA-I, -II and -III was 89.6%, 91.0% and 97.6%, respectively. The annual incremental cost (estimated by the total incremental cost at 12 months) between ERA-II and ERA-I was $Can1723. The incremental cost-effectiveness ratios between ERA-III and ERA-I, and between ERA-III and ERA-II were $Can58 806 and $Can46 971 per life-year gained, respectively. CONCLUSION: We found the cost effectiveness of ERA-III ART regimens well within the range of currently funded therapies for the treatment of other chronic diseases. More... »

PAGES

393-404

Identifiers

URI

http://scigraph.springernature.com/pub.10.2165/00019053-200018040-00007

DOI

http://dx.doi.org/10.2165/00019053-200018040-00007

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1024075285

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/15344307


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Acquired Immunodeficiency Syndrome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-HIV Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cost-Benefit Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Health Care Costs", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of British Columbia", 
          "id": "https://www.grid.ac/institutes/grid.17091.3e", 
          "name": [
            "British Columbia Centre for Excellence in HIV/AIDS, St. Paul\u2019s Hospital, Vancouver, British Columbia, Canada", 
            "Canadian HIV Trials Network, Vancouver, British Columbia, Canada", 
            "Department of Health Care and Epidemiology, University of British Columbia, Vancouver, British Columbia, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Anis", 
        "givenName": "Aslam H.", 
        "id": "sg:person.01340462506.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340462506.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Canadian HIV Trials Network, Vancouver, British Columbia, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Guh", 
        "givenName": "Daphne", 
        "id": "sg:person.0654122412.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0654122412.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of British Columbia", 
          "id": "https://www.grid.ac/institutes/grid.17091.3e", 
          "name": [
            "British Columbia Centre for Excellence in HIV/AIDS, St. Paul\u2019s Hospital, Vancouver, British Columbia, Canada", 
            "Department of Health Care and Epidemiology, University of British Columbia, Vancouver, British Columbia, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hogg", 
        "givenName": "Robert S.", 
        "id": "sg:person.01057070102.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01057070102.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Canadian HIV Trials Network, Vancouver, British Columbia, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wang", 
        "givenName": "Xiao-Hua", 
        "id": "sg:person.01133246574.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01133246574.60"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "St. Paul's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.416553.0", 
          "name": [
            "British Columbia Centre for Excellence in HIV/AIDS, St. Paul\u2019s Hospital, Vancouver, British Columbia, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yip", 
        "givenName": "Benita", 
        "id": "sg:person.01160746452.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01160746452.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Canadian HIV Trials Network, Vancouver, British Columbia, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Craib", 
        "givenName": "Kevin J. P.", 
        "id": "sg:person.01211241175.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211241175.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of British Columbia", 
          "id": "https://www.grid.ac/institutes/grid.17091.3e", 
          "name": [
            "British Columbia Centre for Excellence in HIV/AIDS, St. Paul\u2019s Hospital, Vancouver, British Columbia, Canada", 
            "Canadian HIV Trials Network, Vancouver, British Columbia, Canada", 
            "Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "O\u2019Shaughnessy", 
        "givenName": "Michael V.", 
        "id": "sg:person.0663251475.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663251475.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of British Columbia", 
          "id": "https://www.grid.ac/institutes/grid.17091.3e", 
          "name": [
            "British Columbia Centre for Excellence in HIV/AIDS, St. Paul\u2019s Hospital, Vancouver, British Columbia, Canada", 
            "Canadian HIV Trials Network, Vancouver, British Columbia, Canada", 
            "Department of Health Care and Epidemiology, University of British Columbia, Vancouver, British Columbia, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schechter", 
        "givenName": "Martin T.", 
        "id": "sg:person.016444275112.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016444275112.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of British Columbia", 
          "id": "https://www.grid.ac/institutes/grid.17091.3e", 
          "name": [
            "British Columbia Centre for Excellence in HIV/AIDS, St. Paul\u2019s Hospital, Vancouver, British Columbia, Canada", 
            "Canadian HIV Trials Network, Vancouver, British Columbia, Canada", 
            "Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Montaner", 
        "givenName": "Julio S. G.", 
        "id": "sg:person.015212221772.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015212221772.29"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.2165/00019053-199712010-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003832056", 
          "https://doi.org/10.2165/00019053-199712010-00006"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002030-198906000-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004321333"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002030-198906000-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004321333"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00019053-199610020-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005281811", 
          "https://doi.org/10.2165/00019053-199610020-00001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0277-9536(93)90315-u", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009374126"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002030-199803000-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013608384"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002030-199803000-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013608384"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002030-199803000-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013608384"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002030-199906180-00016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020821681"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002030-199906180-00016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020821681"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002030-199906180-00016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020821681"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1017/s0266462300009247", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024918358"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.1997.03540480062040", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028003169"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00019053-199610020-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029089270", 
          "https://doi.org/10.2165/00019053-199610020-00002"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.279.2.130", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045751367"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00019053-199813060-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048200509", 
          "https://doi.org/10.2165/00019053-199813060-00006"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.279.6.450", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048803673"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.277.24.1962", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054161127"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.3277273", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062603638"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2307/135872", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069444642"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-114-9-798", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073695493"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074273632", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075422566", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075880389", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077955878", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079555624", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2000-10", 
    "datePublishedReg": "2000-10-01", 
    "description": "OBJECTIVE: To estimate survival, the number of life-years gained and cost effectiveness of antiretroviral therapy (ART) regimens, denoted as ERA-I [zidovudine + (didanosine or zalcitabine)]; ERA-II [stavudine + (didanosine or zalcitabine) or lamivudine + (zidovudine or didanosine or zalcitabine or stavudine)]; and ERA-III [2 nucleoside reverse transcriptase inhibitors + (1 protease inhibitor or 1 non-nucleoside reverse transcriptase inhibitor)].\nDESIGN: Modelling of drug cost, cost of opportunistic diseases and survival of HIV positive men and women in the province of British Columbia who were first prescribed any ART between October 1992 and June 1996. A 'reference cohort' was modelled upon individuals in a longitudinal cohort of homosexual men followed since 1982. PERSPECTIVE AND SETTING: Third-party payer perspective in British Columbia, Canada.\nPATIENTS: All HIV-positive men and women aged > or =18 years with CD4+ counts < or =350 cells/microL who were enrolled in the province-wide drug treatment programme.\nMAIN OUTCOME MEASURES: Annual costs, survival and cost-effectiveness ratios of successive ART regimens.\nRESULTS: Total costs [1997 Canadian dollars ($Can)] at 12 months under ERA-I, -II and -III were $Can4897, $Can6620 and $Can 11 914, respectively. Survival at 12 months under ERA-I, -II and -III was 89.6%, 91.0% and 97.6%, respectively. The annual incremental cost (estimated by the total incremental cost at 12 months) between ERA-II and ERA-I was $Can1723. The incremental cost-effectiveness ratios between ERA-III and ERA-I, and between ERA-III and ERA-II were $Can58 806 and $Can46 971 per life-year gained, respectively.\nCONCLUSION: We found the cost effectiveness of ERA-III ART regimens well within the range of currently funded therapies for the treatment of other chronic diseases.", 
    "genre": "research_article", 
    "id": "sg:pub.10.2165/00019053-200018040-00007", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1102812", 
        "issn": [
          "1170-7690", 
          "1179-2027"
        ], 
        "name": "PharmacoEconomics", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "18"
      }
    ], 
    "name": "The Cost Effectiveness of Antiretroviral Regimens for the Treatment of HIV/AIDS", 
    "pagination": "393-404", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "72b3607ca5271e8c3f9fadb8643553d840fb9d1d0ced07f38f5458292191f040"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "15344307"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9212404"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.2165/00019053-200018040-00007"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1024075285"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.2165/00019053-200018040-00007", 
      "https://app.dimensions.ai/details/publication/pub.1024075285"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:35", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000363_0000000363/records_70027_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.2165/00019053-200018040-00007"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.2165/00019053-200018040-00007'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.2165/00019053-200018040-00007'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.2165/00019053-200018040-00007'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.2165/00019053-200018040-00007'


 

This table displays all metadata directly associated to this object as RDF triples.

240 TRIPLES      21 PREDICATES      60 URIs      31 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.2165/00019053-200018040-00007 schema:about N357f58cbf3ab457eb51fab39c61fe1f9
2 N3800ef52dc0c425aa13f9b33436395aa
3 N39666c011fe04cc3b9662a374dac3f4b
4 N4d1bc4678bd840e6bfef885d213e7430
5 N6f0b2cd2f7e547e7987b2263a3a542a7
6 Nb63cbcf1903b42718ba5f34bd3995477
7 Nc1ce5248afba48058b25547c88f99baf
8 Nce81926e2cd64739b5c219b3e9d01676
9 Ncf63db07a2784347afa12aa8f5511c63
10 Nf5cda9d0bebd42ef940cb6cd7cdfd451
11 anzsrc-for:11
12 anzsrc-for:1117
13 schema:author N436ac9d111814c81b6e33fad031335d7
14 schema:citation sg:pub.10.2165/00019053-199610020-00001
15 sg:pub.10.2165/00019053-199610020-00002
16 sg:pub.10.2165/00019053-199712010-00006
17 sg:pub.10.2165/00019053-199813060-00006
18 https://app.dimensions.ai/details/publication/pub.1074273632
19 https://app.dimensions.ai/details/publication/pub.1075422566
20 https://app.dimensions.ai/details/publication/pub.1075880389
21 https://app.dimensions.ai/details/publication/pub.1077955878
22 https://app.dimensions.ai/details/publication/pub.1079555624
23 https://doi.org/10.1001/jama.1997.03540480062040
24 https://doi.org/10.1001/jama.277.24.1962
25 https://doi.org/10.1001/jama.279.2.130
26 https://doi.org/10.1001/jama.279.6.450
27 https://doi.org/10.1016/0277-9536(93)90315-u
28 https://doi.org/10.1017/s0266462300009247
29 https://doi.org/10.1097/00002030-198906000-00002
30 https://doi.org/10.1097/00002030-199803000-00005
31 https://doi.org/10.1097/00002030-199906180-00016
32 https://doi.org/10.1126/science.3277273
33 https://doi.org/10.2307/135872
34 https://doi.org/10.7326/0003-4819-114-9-798
35 schema:datePublished 2000-10
36 schema:datePublishedReg 2000-10-01
37 schema:description OBJECTIVE: To estimate survival, the number of life-years gained and cost effectiveness of antiretroviral therapy (ART) regimens, denoted as ERA-I [zidovudine + (didanosine or zalcitabine)]; ERA-II [stavudine + (didanosine or zalcitabine) or lamivudine + (zidovudine or didanosine or zalcitabine or stavudine)]; and ERA-III [2 nucleoside reverse transcriptase inhibitors + (1 protease inhibitor or 1 non-nucleoside reverse transcriptase inhibitor)]. DESIGN: Modelling of drug cost, cost of opportunistic diseases and survival of HIV positive men and women in the province of British Columbia who were first prescribed any ART between October 1992 and June 1996. A 'reference cohort' was modelled upon individuals in a longitudinal cohort of homosexual men followed since 1982. PERSPECTIVE AND SETTING: Third-party payer perspective in British Columbia, Canada. PATIENTS: All HIV-positive men and women aged > or =18 years with CD4+ counts < or =350 cells/microL who were enrolled in the province-wide drug treatment programme. MAIN OUTCOME MEASURES: Annual costs, survival and cost-effectiveness ratios of successive ART regimens. RESULTS: Total costs [1997 Canadian dollars ($Can)] at 12 months under ERA-I, -II and -III were $Can4897, $Can6620 and $Can 11 914, respectively. Survival at 12 months under ERA-I, -II and -III was 89.6%, 91.0% and 97.6%, respectively. The annual incremental cost (estimated by the total incremental cost at 12 months) between ERA-II and ERA-I was $Can1723. The incremental cost-effectiveness ratios between ERA-III and ERA-I, and between ERA-III and ERA-II were $Can58 806 and $Can46 971 per life-year gained, respectively. CONCLUSION: We found the cost effectiveness of ERA-III ART regimens well within the range of currently funded therapies for the treatment of other chronic diseases.
38 schema:genre research_article
39 schema:inLanguage en
40 schema:isAccessibleForFree false
41 schema:isPartOf N40e2d96c797b4d00aa20d852c95d56b4
42 Nb6708b7f04ac4d92a50e34206cc68a28
43 sg:journal.1102812
44 schema:name The Cost Effectiveness of Antiretroviral Regimens for the Treatment of HIV/AIDS
45 schema:pagination 393-404
46 schema:productId N00acc24baab343dbb61e4f1cd86c9992
47 N0aa919684a0643c89e986ea93a3b2762
48 N10e59ec9193540f28624960436c574b4
49 N726175fb62ff480e8effe89a87095005
50 N9a1d6020146c40eab1c284e9cfaaa311
51 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024075285
52 https://doi.org/10.2165/00019053-200018040-00007
53 schema:sdDatePublished 2019-04-11T12:35
54 schema:sdLicense https://scigraph.springernature.com/explorer/license/
55 schema:sdPublisher N674ca854cb774d6e92c0b61d89de33be
56 schema:url http://link.springer.com/10.2165/00019053-200018040-00007
57 sgo:license sg:explorer/license/
58 sgo:sdDataset articles
59 rdf:type schema:ScholarlyArticle
60 N00acc24baab343dbb61e4f1cd86c9992 schema:name doi
61 schema:value 10.2165/00019053-200018040-00007
62 rdf:type schema:PropertyValue
63 N0aa919684a0643c89e986ea93a3b2762 schema:name nlm_unique_id
64 schema:value 9212404
65 rdf:type schema:PropertyValue
66 N10e59ec9193540f28624960436c574b4 schema:name pubmed_id
67 schema:value 15344307
68 rdf:type schema:PropertyValue
69 N1cd1d68326d7483e9d097cb44b01305b rdf:first sg:person.01211241175.66
70 rdf:rest Nf34a4ce62c99476b9c743fb60c68e502
71 N357f58cbf3ab457eb51fab39c61fe1f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Adult
73 rdf:type schema:DefinedTerm
74 N3800ef52dc0c425aa13f9b33436395aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Male
76 rdf:type schema:DefinedTerm
77 N39666c011fe04cc3b9662a374dac3f4b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Drug Therapy, Combination
79 rdf:type schema:DefinedTerm
80 N40e2d96c797b4d00aa20d852c95d56b4 schema:issueNumber 4
81 rdf:type schema:PublicationIssue
82 N436ac9d111814c81b6e33fad031335d7 rdf:first sg:person.01340462506.44
83 rdf:rest N44bfeae49d25415ea67da9e3875214e9
84 N44bfeae49d25415ea67da9e3875214e9 rdf:first sg:person.0654122412.16
85 rdf:rest Nf28a2e91f0e74541a59d0905cf622be5
86 N4d1bc4678bd840e6bfef885d213e7430 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Middle Aged
88 rdf:type schema:DefinedTerm
89 N5fab9838632e4cdabad94e592f1fd515 rdf:first sg:person.015212221772.29
90 rdf:rest rdf:nil
91 N674ca854cb774d6e92c0b61d89de33be schema:name Springer Nature - SN SciGraph project
92 rdf:type schema:Organization
93 N6abf44a0afd14a139cbf3b36b2a06f97 schema:name Canadian HIV Trials Network, Vancouver, British Columbia, Canada
94 rdf:type schema:Organization
95 N6f0b2cd2f7e547e7987b2263a3a542a7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Female
97 rdf:type schema:DefinedTerm
98 N726175fb62ff480e8effe89a87095005 schema:name readcube_id
99 schema:value 72b3607ca5271e8c3f9fadb8643553d840fb9d1d0ced07f38f5458292191f040
100 rdf:type schema:PropertyValue
101 N7632af44e4f442f68bd6f28d6579c7cb rdf:first sg:person.016444275112.20
102 rdf:rest N5fab9838632e4cdabad94e592f1fd515
103 N9a1d6020146c40eab1c284e9cfaaa311 schema:name dimensions_id
104 schema:value pub.1024075285
105 rdf:type schema:PropertyValue
106 N9a2e171f62b7470e9152c5801606dd3b schema:name Canadian HIV Trials Network, Vancouver, British Columbia, Canada
107 rdf:type schema:Organization
108 Na1d8a833c2054bb88460070464fcb637 rdf:first sg:person.01133246574.60
109 rdf:rest Ne02b7691eeb24c66aff3314be9899b2a
110 Na7d91703dca74e048efe6d2e7c86b5d7 schema:name Canadian HIV Trials Network, Vancouver, British Columbia, Canada
111 rdf:type schema:Organization
112 Nb63cbcf1903b42718ba5f34bd3995477 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Anti-HIV Agents
114 rdf:type schema:DefinedTerm
115 Nb6708b7f04ac4d92a50e34206cc68a28 schema:volumeNumber 18
116 rdf:type schema:PublicationVolume
117 Nc1ce5248afba48058b25547c88f99baf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Cost-Benefit Analysis
119 rdf:type schema:DefinedTerm
120 Nce81926e2cd64739b5c219b3e9d01676 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Humans
122 rdf:type schema:DefinedTerm
123 Ncf63db07a2784347afa12aa8f5511c63 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Acquired Immunodeficiency Syndrome
125 rdf:type schema:DefinedTerm
126 Ne02b7691eeb24c66aff3314be9899b2a rdf:first sg:person.01160746452.90
127 rdf:rest N1cd1d68326d7483e9d097cb44b01305b
128 Nf28a2e91f0e74541a59d0905cf622be5 rdf:first sg:person.01057070102.49
129 rdf:rest Na1d8a833c2054bb88460070464fcb637
130 Nf34a4ce62c99476b9c743fb60c68e502 rdf:first sg:person.0663251475.19
131 rdf:rest N7632af44e4f442f68bd6f28d6579c7cb
132 Nf5cda9d0bebd42ef940cb6cd7cdfd451 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Health Care Costs
134 rdf:type schema:DefinedTerm
135 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
136 schema:name Medical and Health Sciences
137 rdf:type schema:DefinedTerm
138 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
139 schema:name Public Health and Health Services
140 rdf:type schema:DefinedTerm
141 sg:journal.1102812 schema:issn 1170-7690
142 1179-2027
143 schema:name PharmacoEconomics
144 rdf:type schema:Periodical
145 sg:person.01057070102.49 schema:affiliation https://www.grid.ac/institutes/grid.17091.3e
146 schema:familyName Hogg
147 schema:givenName Robert S.
148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01057070102.49
149 rdf:type schema:Person
150 sg:person.01133246574.60 schema:affiliation N6abf44a0afd14a139cbf3b36b2a06f97
151 schema:familyName Wang
152 schema:givenName Xiao-Hua
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01133246574.60
154 rdf:type schema:Person
155 sg:person.01160746452.90 schema:affiliation https://www.grid.ac/institutes/grid.416553.0
156 schema:familyName Yip
157 schema:givenName Benita
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01160746452.90
159 rdf:type schema:Person
160 sg:person.01211241175.66 schema:affiliation N9a2e171f62b7470e9152c5801606dd3b
161 schema:familyName Craib
162 schema:givenName Kevin J. P.
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211241175.66
164 rdf:type schema:Person
165 sg:person.01340462506.44 schema:affiliation https://www.grid.ac/institutes/grid.17091.3e
166 schema:familyName Anis
167 schema:givenName Aslam H.
168 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340462506.44
169 rdf:type schema:Person
170 sg:person.015212221772.29 schema:affiliation https://www.grid.ac/institutes/grid.17091.3e
171 schema:familyName Montaner
172 schema:givenName Julio S. G.
173 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015212221772.29
174 rdf:type schema:Person
175 sg:person.016444275112.20 schema:affiliation https://www.grid.ac/institutes/grid.17091.3e
176 schema:familyName Schechter
177 schema:givenName Martin T.
178 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016444275112.20
179 rdf:type schema:Person
180 sg:person.0654122412.16 schema:affiliation Na7d91703dca74e048efe6d2e7c86b5d7
181 schema:familyName Guh
182 schema:givenName Daphne
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0654122412.16
184 rdf:type schema:Person
185 sg:person.0663251475.19 schema:affiliation https://www.grid.ac/institutes/grid.17091.3e
186 schema:familyName O’Shaughnessy
187 schema:givenName Michael V.
188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663251475.19
189 rdf:type schema:Person
190 sg:pub.10.2165/00019053-199610020-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005281811
191 https://doi.org/10.2165/00019053-199610020-00001
192 rdf:type schema:CreativeWork
193 sg:pub.10.2165/00019053-199610020-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029089270
194 https://doi.org/10.2165/00019053-199610020-00002
195 rdf:type schema:CreativeWork
196 sg:pub.10.2165/00019053-199712010-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003832056
197 https://doi.org/10.2165/00019053-199712010-00006
198 rdf:type schema:CreativeWork
199 sg:pub.10.2165/00019053-199813060-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048200509
200 https://doi.org/10.2165/00019053-199813060-00006
201 rdf:type schema:CreativeWork
202 https://app.dimensions.ai/details/publication/pub.1074273632 schema:CreativeWork
203 https://app.dimensions.ai/details/publication/pub.1075422566 schema:CreativeWork
204 https://app.dimensions.ai/details/publication/pub.1075880389 schema:CreativeWork
205 https://app.dimensions.ai/details/publication/pub.1077955878 schema:CreativeWork
206 https://app.dimensions.ai/details/publication/pub.1079555624 schema:CreativeWork
207 https://doi.org/10.1001/jama.1997.03540480062040 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028003169
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1001/jama.277.24.1962 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054161127
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1001/jama.279.2.130 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045751367
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1001/jama.279.6.450 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048803673
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1016/0277-9536(93)90315-u schema:sameAs https://app.dimensions.ai/details/publication/pub.1009374126
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1017/s0266462300009247 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024918358
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1097/00002030-198906000-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004321333
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1097/00002030-199803000-00005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013608384
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1097/00002030-199906180-00016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020821681
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1126/science.3277273 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062603638
226 rdf:type schema:CreativeWork
227 https://doi.org/10.2307/135872 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069444642
228 rdf:type schema:CreativeWork
229 https://doi.org/10.7326/0003-4819-114-9-798 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073695493
230 rdf:type schema:CreativeWork
231 https://www.grid.ac/institutes/grid.17091.3e schema:alternateName University of British Columbia
232 schema:name British Columbia Centre for Excellence in HIV/AIDS, St. Paul’s Hospital, Vancouver, British Columbia, Canada
233 Canadian HIV Trials Network, Vancouver, British Columbia, Canada
234 Department of Health Care and Epidemiology, University of British Columbia, Vancouver, British Columbia, Canada
235 Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
236 Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada
237 rdf:type schema:Organization
238 https://www.grid.ac/institutes/grid.416553.0 schema:alternateName St. Paul's Hospital
239 schema:name British Columbia Centre for Excellence in HIV/AIDS, St. Paul’s Hospital, Vancouver, British Columbia, Canada
240 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...